Cost-effectiveness of enoxaparin compared with unfractionated heparin in ST elevation myocardial infarction patients undergoing pharmacological reperfusion: A Canadian analysis of the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment – Thrombolysis in Myocardial Infarction (ExTRACT-TIMI) 25 trial

OBJECTIVE: To evaluate the cost-effectiveness of enoxaparin versus unfractionated heparin in conjunction with fibrinolysis in ST elevation myocardial infarction patients within Canada. DESIGN: Based on the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment – Thrombolys...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Welsh, Robert C, Sauriol, Luc, Zhang, Zugui, Kolm, Paul, Weintraub, William S, Theroux, Pierre
Médium: Artigo
Jazyk:Inglês
Vydáno: Pulsus Group Inc 2009
Témata:
Health Outcomes/Public Policy
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2807835/
https://ncbi.nlm.nih.gov/pubmed/19960133
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky